Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients
2021 · BMC Cancer · 86 citations
https://doi.org/10.1186/s12885-021-08428-w
J
Jinbin Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
154
Papers
2.1K
Citations
26
h-index
56
i10-index
Jinbin Chen is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cholangiocarcinoma and Gallbladder Cancer Studies & Cancer Mechanisms and Therapy. The author has an h-index of 26, co-authored 131 publications.
ORCID: 0000-0002-6619-1247Papers by this author
worksEnhanced creep resistance induced by minor Ti additions to a second generation nickel-based single crystal superalloy
2022 · Acta Materialia · 80 citations
https://doi.org/10.1016/j.actamat.2022.117938
Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma
2016 · Chinese Journal of Cancer · 45 citations
https://doi.org/10.1186/s40880-016-0088-0
Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers
2020 · Cancer Research and Treatment · 31 citations
https://doi.org/10.4143/crt.2020.594
Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma
2025 · Radiology · 16 citations
https://doi.org/10.1148/radiol.241096
Dynamic changes of serum α-fetoprotein predict the prognosis of bevacizumab plus immunotherapy in hepatocellular carcinoma
2024 · International Journal of Surgery · 13 citations
https://doi.org/10.1097/js9.0000000000001860
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat